The granting of a new patent to Avinger, Inc. is significant as it directly relates to the company's core products and technologies. This development could lead to enhanced market competitiveness and innovation, making it a positive signal for investors. The patent covers key areas such as occlusion-crossing devices, imaging, and atherectomy devices, which are central to Avinger's product lineup. This could potentially lead to new product developments or improvements in existing products, thereby strengthening Avinger's position in the medical device market.